Treatment of acute hepatitis C genotypes 1 and 4 with 8 weeks of grazoprevir plus elbasvir (DAHHS2): an open-label, multicentre, single-arm, phase 3b trial
| Autor: | Boerekamps, Anne, De Weggheleire, Anja, van den Berk, Guido E, Lauw, Fanny N, Claassen, Mark A A, Posthouwer, Dirk, Bierman, Wouter F, Hullegie, Sebastiaan J, Popping, Stephanie, van de Vijver, David A C M, Dofferhoff, Anthonius S M, Kootstra, Gert Jan, Leyten, Eliane M, den Hollander, Jan, van Kasteren, Marjo E, Soetekouw, Robert, Ammerlaan, Heidi S M, Schinkel, Janke, Florence, Eric, Arends, Joop E, Rijnders, Bart J A |
|---|---|
| Zdroj: | In The Lancet Gastroenterology & Hepatology April 2019 4(4):269-277 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|